You are here

Harm reduction

It's good to know

It's Good To Know

by
Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)

This leaflet is the part of  Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT). 

Leaflets and posters for people who use drugs (PWUD) have been prepared by the Work package 4 “Testing and linkage to care” to promote rapid HIV and HCV tests in low threshold...

Tags: Injecting drug users (IDUs), People who use drugs (PUD), WHO European region, Co-infections, Harm reduction, Inequalities in health, Social issues, Testing and counselling
Read more
Bridiging the Gaps Tajikistan

Using drugs reducing risks - Improving access to healthcare for people who use drugs in Tajikistan

by
Bridging the Gaps

BRIDGING THE GAPS:  an international HIV Programme on health and rights for LGBT people, sex workers and people who use drugs.  Video from the programme on improving access to healthcare for people who use drugs in Tajikistan

In Tajikistan an estimated 25,000 people are using drugs....

Tags: Injecting drug users (IDUs), People who use drugs (PUD), Central Asia, Harm reduction, Inequalities in health, Universal access
Read more
Bridging the Gaps Ukraine

Today’s youth, tomorrow’s key populations?

by
Bridiging the Gaps

BRIDGING THE GAPS:  an international HIV Programme on health and rights for LGBT people, sex workers and people who use drugs.  Video from the programme on supporting adolescents at risk of HIV in Ukraine. 

Tags: Heterosexuals, Injecting drug users (IDUs), People who use drugs (PUD), Women, Eastern Europe, Care and support, Harm reduction, Inequalities in health, Social issues
Read more
WHO Transgender people and HIV

Transgender people and HIV. Policy brief

by
World Healith Organization

This technical brief summarizes essential information and existing WHO recommendations for HIV prevention, diagnosis, treatment and care among transgender populations.

Tags: LGBTI, People living with HIV (PLHIV), Sex workers, Global, Care and support, Co-infections, Epidemiology, Gender, Harm reduction, Human rights, Pre-exposure prophylaxis (PrEP), Prevention, Reproductive health, Sexual and reproductive health, Stigma and discrimination, Testing and counselling, Treatment, Tubercolosis, Viral hepatitis
Read more
European Drug Report 2016 - Trends and Developments

European Drug Report 2016: Trends and Developments

by
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin, Country Overviews and Perspectives on Drugs, it makes up...

Tags: Health care professionals, Injecting drug users (IDUs), NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Laws and regulations, Legislation, Monitoring and Evaluation, Policy, Prevention, Research, Treatment
Read more
European Drug Report 2015: Trends and Developments

European Drug Report 2015: Trends and Developments

by
European Monitoring Centre for Drugs and Drug Addiction

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European Drug Report 2015: Trends and Developments. This years’ annual review reflects on 20...

Tags: General public, Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Monitoring and Evaluation, Policy, Prevention, Treatment, Viral hepatitis
Read more
Preventing opioid overdose deaths with take-home naloxone

Preventing opioid overdose deaths with take-home naloxone

by
European Monitoring Centre for Drugs and Drug Addiction

This publication examines the case for distributing naloxone, an emergency medication, to people who inject opioids such as heroin and to others who might witness an opioid overdose. Through its capacity to reverse opioid overdose, naloxone can save lives if administered in time. This...

Tags: Health care professionals, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Affordability, Care and support, Harm reduction, Policy, Prevention, Treatment
Read more
Drug-related infectious diseases in Europ

Drug-related infectious diseases in Europe

by
European Monitoring Centre for Drugs and Drug Addiction

This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. It includes highlights...

Tags: General public, Health care professionals, NGOs, People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Policy, Prevention, Treatment, Viral hepatitis
Read more

Twitter News

Sign up for our Newsletter